Evidence map›Paper›PMID 27357688›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Genome engineering uncovers 54 evolutionarily conserved and testis-enriched genes that are not required for male fertility in mice.

Haruhiko Miyata, Julio M Castaneda, Yoshitaka Fujihara, Zhifeng Yu, Denise R Archambeault, Ayako Isotani, Daiji Kiyozumi, Maya L Kriseman, Daisuke Mashiko, Takafumi Matsumura and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 168 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Normal spermatogenesis and fertility inBiochemistry and biophysics reports · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. American journal of translational research · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Deletion ofFrontiers in cell and developmental biology · 2024
    Article
  19. Article
  20. Article

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 4 countries.

Haruhiko MiyataResearch Institute for Microbial Diseases, Osaka University, Suita, Osaka 5650871, Japan;
Julio M CastanedaDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030; Center for Reproductive Medicine, Baylor College of Medicine, Houston, TX 77030;
Yoshitaka FujiharaResearch Institute for Microbial Diseases, Osaka University, Suita, Osaka 5650871, Japan;
Zhifeng YuDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030; Center for Drug Discovery, Baylor College of Medicine, Houston, TX 77030;
Denise R ArchambeaultDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030; Center for Reproductive Medicine, Baylor College of Medicine, Houston, TX 77030;
Ayako IsotaniImmunology Frontier Research Center, Osaka University, Suita, Osaka 5650871, Japan;
Daiji KiyozumiImmunology Frontier Research Center, Osaka University, Suita, Osaka 5650871, Japan;
Maya L KrisemanDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030; Center for Reproductive Medicine, Baylor College of Medicine, Houston, TX 77030;
Daisuke MashikoResearch Institute for Microbial Diseases, Osaka University, Suita, Osaka 5650871, Japan; Graduate School of Medicine, Osaka University, Suita, Osaka 5650871, Japan;
Takafumi MatsumuraResearch Institute for Microbial Diseases, Osaka University, Suita, Osaka 5650871, Japan; Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka 5650871, Japan;
Ryan M MatzukDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030;
Masashi MoriResearch Institute for Microbial Diseases, Osaka University, Suita, Osaka 5650871, Japan;
Taichi NodaResearch Institute for Microbial Diseases, Osaka University, Suita, Osaka 5650871, Japan;
Asami OjiResearch Institute for Microbial Diseases, Osaka University, Suita, Osaka 5650871, Japan; Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka 5650871, Japan;
Masaru OkabeResearch Institute for Microbial Diseases, Osaka University, Suita, Osaka 5650871, Japan;
Renata Prunskaite-HyyrylainenDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030; Center for Reproductive Medicine, Baylor College of Medicine, Houston, TX 77030; Faculty of Biochemistry and Molecular Medicine, University of Oulu, FI-90014, Oulu, Finland;
Ramiro Ramirez-SolisWellcome Trust Sanger Institute, Hinxton CB10 1SA, United Kingdom;
Yuhkoh SatouhResearch Institute for Microbial Diseases, Osaka University, Suita, Osaka 5650871, Japan;
Qian ZhangResearch Institute for Microbial Diseases, Osaka University, Suita, Osaka 5650871, Japan;
Masahito IkawaResearch Institute for Microbial Diseases, Osaka University, Suita, Osaka 5650871, Japan; Immunology Frontier Research Center, Osaka University, Suita, Osaka 5650871, Japan; Graduate School of Medicine, Osaka University, Suita, Osaka 5650871, Japan; Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka 5650871, Japan; ikawa@biken.osaka-u.ac.jp mmatzuk@bcm.edu.
Martin M MatzukDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030; Center for Reproductive Medicine, Baylor College of Medicine, Houston, TX 77030; Center for Drug Discovery, Baylor College of Medicine, Houston, TX 77030; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030; Department of Pharmacology, Baylor College of Medicine, Houston, TX 77030 ikawa@biken.osaka-u.ac.jp mmatzuk@bcm.edu.
Osaka University · JPBaylor College of Medicine · USWellcome Sanger Institute · GB

Funding

High-throughput targeted mutagenesis of mouse stem cell linesU01HG004080 · NHGRI · CHILDREN'S HOSPITAL & RES CTR AT OAKLAND · PI DE JONG, PIETER J. · 2006 to 2010
$28.1M
REPRODUCTIVE BIOLOGY: REGULATORY MECHANISMST32HD007165 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI O'MALLEY, BERT W · 1985 to 2015
$5.6M
identification of small molecule contraceptives that target the male germlineU01HD060496 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI MATZUK, MARTIN M. · 2009 to 2013
$1.2M
Selective inhibition of BRDT for male contraceptionU01HD076508 · NICHD · DANA-FARBER CANCER INST · PI QI, JUN · 2012 to 2016
$1.2M
NHGRI NIH HHS U01 HG004080NICHD NIH HHS T32 HD007165NICHD NIH HHS U01 HD060496NICHD NIH HHS U01 HD076508Wellcome Trust 079643Wellcome Trust 098051
6 · The paper itself

Abstract

Gene-expression analysis studies from Schultz et al. estimate that more than 2,300 genes in the mouse genome are expressed predominantly in the male germ line. As of their 2003 publication [Schultz N, Hamra FK, Garbers DL (2003) Proc Natl Acad Sci USA 100(21):12201-12206], the functions of the majority of these testis-enriched genes during spermatogenesis and fertilization were largely unknown. Since the study by Schultz et al., functional analysis of hundreds of reproductive-tract-enriched genes have been performed, but there remain many testis-enriched genes for which their relevance to reproduction remain unexplored or unreported. Historically, a gene knockout is the "gold standard" to determine whether a gene's function is essential in vivo. Although knockout mice without apparent phenotypes are rarely published, these knockout mouse lines and their phenotypic information need to be shared to prevent redundant experiments. Herein, we used bioinformatic and experimental approaches to uncover mouse testis-enriched genes that are evolutionarily conserved in humans. We then used gene-disruption approaches, including Knockout Mouse Project resources (targeting vectors and mice) and CRISPR/Cas9, to mutate and quickly analyze the fertility of these mutant mice. We discovered that 54 mutant mouse lines were fertile. Thus, despite evolutionary conservation of these genes in vertebrates and in some cases in all eukaryotes, our results indicate that these genes are not individually essential for male mouse fertility. Our phenotypic data are highly relevant in this fiscally tight funding period and postgenomic age when large numbers of genomes are being analyzed for disease association, and will prevent unnecessary expenditures and duplications of effort by others.

Indexed as

AnimalsBiological EvolutionCRISPR-Cas SystemsFemaleFertilityFertilizationGenetic EngineeringGenomicsMaleMiceMice, KnockoutSpermatogenesisTestisgenetically modified micegenome editingspermatozoa

Identifiers

PMID27357688
PMCPMC4948324
OpenAlexW2470951287

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.